Gts Securities »

Regeneron Pharmaceuticals shares owned by Gts Securities

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Gts Securities from 13F filings

Historical chart of Gts Securities investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Gts Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Gts Securities

Quarter filed Position value Share count Share price at filing
2024-03-31 $32M 33k 962.49
2023-12-31 $42M 48k 878.29
2023-09-30 $35M 43k 822.96

More positions owned by Gts Securities

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
NVIDIA Corporation Put Option (NVDA)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Microsoft Corporation Put Option (MSFT)
Meta Platforms Cl A Put Option (META)
Amazon Put Option (AMZN)
Netflix Put Option (NFLX)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Tesla Motors Put Option (TSLA)
Alphabet Cap Stk Cl C Put Option (GOOG)
Apple Put Option (AAPL)
Alphabet Cap Stk Cl A Put Option (GOOGL)
Broadcom Put Option (AVGO)
Advanced Micro Devices Put Option (AMD)
Microstrategy Cl A New Put Option (MSTR)

View all positions for Gts Securities

Top funds holding Regeneron Pharmaceuticals

FMR
Vanguard Group
BlackRock
Jpmorgan Chase & Co
Geode Capital Management
Dodge & Cox
Franklin Resources
Morgan Stanley
Loomis, Sayles and
Wellington Management Company
Amundi
Northern Trust
Legal & General Group
Bank of America Corporation
T. Rowe Price Associates

View all funds holding Regeneron Pharmaceuticals